NCT01488279View on ClinicalTrials.gov

Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

December 31, 2015

Conditions
Pre-diabetesImpaired Fasting GlucoseImpaired Glucose Tolerance
Interventions
DRUG

Dexamethasone 2.5 mg and Sitagliptin 100 mg

Participants received Dexamethasone 2.5mg plus Sitaliptin 100mg daily for 8 days

DRUG

Dexamethasone 2.5 mg and placebo tablet

Participants rececived Dexamethasone 2.5 mg plus placebo tablet daily for 8 days

Trial Locations (1)

05403

University of Vermont Clinical Research Center, South Burlington

All Listed Sponsors
lead

University of Vermont

OTHER

NCT01488279 - Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy | Biotech Hunter | Biotech Hunter